Sublytic Complement Protects Prostate Cancer Cells from TNF--Induced Cell Death

Clinical and Experimental Immunology, 05/07/2012

The data extend the current view on the induction of tumour cell resistance against cytotoxic mediators supporting the role of the tumour microenvironment in mediating protection against anti–cancer immune response.

Print Article Summary Cat 2 CME Report